The PHC Group is a leading diversified diagnostics, life sciences and medical device company serving global markets through Japanese excellence and precision. We have a platform of established brands, underpinned by our business system that enables us to achieve operational excellence and efficiency through continuous improvement.
*1: Results for the fiscal year ending March 2022, FX rate: 1US$=112.34JPY, 1euro€＝130.49円 *2: As of March 2022 *3: PHC Holdings Corporation not included (as of March 2022)
The PHC Group is comprised of operating companies that provide products and services in the areas of diabetes management, healthcare solutions, and life sciences and diagnostics. Our businesses operate in disease areas that have significant unmet need and represent some of the largest global issues we face today. Our solutions are used by patients, healthcare professionals and researchers in over 125 countries.
The PHC Group leads the healthcare industry with innovative products and services, created with our foundation in manufacturing and precision technology that has been accumulated for over 50 years. Our state-of-the-art solutions are designed to meet the evolving needs of patients, medical professionals and researchers and along the way we have introduced many industry firsts.